(Total Views: 470)
Posted On: 04/16/2022 1:43:37 PM
Post# of 145247
Add to that the fact that what we were told to do, combine data from mono and combo, was somewhat novel for the FDA (as noted by Amarex/Cytodyn on a conference call) and we were guinea pigs on multiple fronts.
![](/m/images/thumb-up.png)
![](/m/images/thumb-down.png)